Abstract Library

#4658 The nutritional status worsens over 5 years in patients with gastroenteropancreatic neuroendocrine tumours on treatment with somatostatin analogues

Introduction: Malnutrition is common in patients with gastroenteropancreatic neuroendocrine tumours (GEP-NETs) treated with monthly somatostatin analogues (SSAs). Ideally all malnourished patients are offered nutritional support. However, clinical guidelines and data on the development and progression of malnutrition is lacking.

Conference:

Presenting Author: Clement D

Authors: Soran V, Srirajaskanthan R, Cananea E, Martin W, Minott S,

Keywords: gastroenteropancreatic neuroendocrine tumour, malnutrition, somatostatin analogue,

#4069 Impact of nutritional status in the quality of life (QoL) of patients with advanced gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs) in Spain: NUTRIGETNE Study

Introduction: Prevalence of malnutrition and sarcopenia is high among patients with advanced GEP-NENs and may significantly decrease response to therapy and impair QoL.

Conference:

Presenting Author:

Authors: Del Olmo-García M, Garcia-Carbonero R, Hernando J, Pérez-Wert P, Suarez Gutiérrez L,

Keywords: nutritional status, Gastroenteropancreatic, Neuroendocrine neoplasm, Sarcopenia, Malnutrition,

#3766 Nutritional status of patients with advanced gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs) in Spain – NUTRIGETNE study

Introduction: Patients (Pts) with advanced GEP-NENs often present with metabolic disorders and oncological treatments may increase malnutrition risk.

Conference:

Presenting Author: Del Olmo-Garcia M

Authors: Hernandez-Rienda L, Hernando Cubero J, Suarez Gutiérrez L, Antón-Pascual B, Alonso V,

Keywords: Nutritional status, GEP-NEN,

#3560 Nutritional status in patients with neuroendocrine tumors: A single ENETS Centre of Excellence experience

Introduction: Studies show that 14–68% of patients with neuroendocrine tumors (NETS) are at risk of or are malnourished. Patients’ dependent on NET type, primary or treatment are at risk of Vitamin B12, A, D E, iron deficiencies, pancreatic enzyme insufficiency (PEI) and a high HbA1c.

Conference:

Presenting Author:

Authors: Burke D, Almeamar H, O'Toole D, Barnes L, Crowley R,

Keywords: malnutrition, deficiencies, Pancreatic enzyme insufficiency, HbA1c's,

#3149 Nutritional assessment for predicting clinical evolution in gastro-enteropancreatic neuroendocrine tumors

Introduction: Patients with neuroendocrine tumors (NETs) might present with malnutrition due to the tumor itself and/or its treatment. Poor nutritional status and weight loss can lead to poor outcomes, including decreased quality of life, increased complication rates and mortality. Furthermore, the impact of body mass index (BMI) as a relevant risk factor for NETs development is currently a very debated topic as data regarding nutritional status in NETs patients are very limited.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author:

Authors: Alzás-Teomiro C, León-Idougourram S, Alcántara-Laguna M, Molina-Puertas M, Gálvez-Moreno M,

Keywords: neuroendocrine, GEP, nutrition,